Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failure
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 24, 31-36
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cutaneous leishmaniasis in French Guiana: revising epidemiology with PCR-RFLPTropical Medicine and Health, 2017
- Global burden of cutaneous leishmaniasis: a cross-sectional analysis from the Global Burden of Disease Study 2013The Lancet Infectious Diseases, 2016
- Épidémiologie des leishmanioses autochtones en France métropolitaine et d’outre-merLa Presse Médicale, 2013
- Traitement des leishmanioses en France : proposition d’un référentiel consensuelLa Presse Médicale, 2011
- Leishmania spp. identification by polymerase chain reaction–restriction fragment length polymorphism analysis and its applications in French GuianaDiagnostic Microbiology and Infectious Disease, 2009
- Leishmaniasis among Gold Miners, French GuianaEmerging Infectious Diseases, 2006
- New world cutaneous leishmaniasis in travellersThe Lancet Infectious Diseases, 2006
- Épidémie de leishmaniose cutanée chez des militaires de retour de mission en GuyaneRevue D'Épidémiologie Et de Santé Publique, 2006
- Seasonal Fluctuations of Incubation, Healing Delays, and Clinical Presentation of Cutaneous Leishmaniasis in French GuianaJournal of Parasitology, 2001
- Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French GuianaPathogens and Global Health, 2001